SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-006505
Filing Date
2023-04-27
Accepted
2023-04-27 17:25:15
Documents
16
Period of Report
2023-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K maia-8k_20230424.htm   iXBRL 8-K 54666
2 EX-1.1 maia-ex11_8.htm EX-1.1 451151
3 EX-99.1 maia-ex991_6.htm EX-99.1 11131
4 EX-99.2 maia-ex992_7.htm EX-99.2 12153
5 GRAPHIC gubxtatrpq3x000001.jpg GRAPHIC 17229
  Complete submission text file 0001564590-23-006505.txt   789246

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA maia-20230424.xsd EX-101.SCH 5585
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20230424_lab.xml EX-101.LAB 20229
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20230424_pre.xml EX-101.PRE 11990
10 EXTRACTED XBRL INSTANCE DOCUMENT maia-8k_20230424_htm.xml XML 3699
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 23858598
SIC: 2834 Pharmaceutical Preparations